GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hoya Corp (OTCPK:HOCPY) » Definitions » 3-Year EBITDA Growth Rate

Hoya (HOCPY) 3-Year EBITDA Growth Rate : 15.50% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Hoya 3-Year EBITDA Growth Rate?

Hoya's EBITDA per Share for the three months ended in Dec. 2023 was $1.22.

During the past 12 months, Hoya's average EBITDA Per Share Growth Rate was 3.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 15.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 13.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Hoya was 39.00% per year. The lowest was -15.30% per year. And the median was 9.80% per year.


Competitive Comparison of Hoya's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Hoya's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hoya's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hoya's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Hoya's 3-Year EBITDA Growth Rate falls into.



Hoya 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Hoya  (OTCPK:HOCPY) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Hoya 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Hoya's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Hoya (HOCPY) Business Description

Traded in Other Exchanges
Address
20th Floor Nishi-Shinjuku Building, 6-10-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 160-8347
Hoya Corp is a diversified, multinational company and supplier of innovative and indispensable high-tech and healthcare products. HOYA is active in two core business segments: The Life Care segment and Information Technology segment. The Life Care segment encompasses health care areas such as eyeglass lenses and the operation of contact lens retail stores, as well as medical endoscopes, surgical equipment and artificial bones and implants. Information Technology segment focuses on electronics products for the semiconductor industry and LCD panels, glass disks for HDDs and optical lenses for digital cameras and smartphones.

Hoya (HOCPY) Headlines

From GuruFocus

Hoya Stock Is Estimated To Be Significantly Overvalued

By GF Value GF Value 06-10-2021

Matthews Japan Fund Comments on HOYA

By Sydnee Gatewood Sydnee Gatewood 07-30-2020

Hoya Stock Is Believed To Be Significantly Overvalued

By GF Value GF Value 04-25-2021

Matthews Japan Fund's Top New Stock Buys of Q3

By Holly LaFon Holly LaFon 11-01-2014